Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Multiple Sclerosis Healthy Subjects”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00913250
What this trial is testing

A Bioequivalence Study of Serum Free Avonex and Serum Containing Avonex in Healthy Volunteers

Who this might be right for
Multiple Sclerosis
Biogen 96
Not applicableEnrolling By InvitationNCT02402426
What this trial is testing

Brain Health Registry: An Online Registry to Identify and Assess Subjects for Brain Research

Who this might be right for
HealthyNeurodegenerative Disease
University of California, San Francisco 200,000
Early research (Phase 1)Study completedNCT00432900
What this trial is testing

Brain Peripheral Benzodiazepine Receptors in Patients With Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
National Institute of Neurological Disorders and Stroke (NINDS) 21
Early research (Phase 1)Study completedNCT01500408
What this trial is testing

Demonstrate the Bioequivalence of Interferon Beta-1a (INFB) Manufactured by Two Different Processes in Healthy Volunteers

Who this might be right for
Multiple Sclerosis
Biogen 110
Early research (Phase 1)Study completedNCT02521545
What this trial is testing

Single-Dose Study of a New Formulation of BIIB061

Who this might be right for
Multiple Sclerosis
Biogen 8
Not applicableEnded earlyNCT01092208
What this trial is testing

Studies of Autistic Patients: Gene Networks and Clinical Subtypes

Who this might be right for
AutismTuberous Sclerosis
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) 11
Early research (Phase 1)Study completedNCT04725175
What this trial is testing

Phase I Study Evaluating Safety and Tolerability of Escalating Single and Multiple Doses of of PIPE-307 and Food Effect in Healthy Volunteers

Who this might be right for
Multiple Sclerosis
Contineum Therapeutics 70
Early research (Phase 1)Study completedNCT03237832
What this trial is testing

ARN-6039

Who this might be right for
Multiple Sclerosis
Arrien Pharmaceuticals 60
Early research (Phase 1)Study completedNCT05795907
What this trial is testing

Single & Multiple Ascending Dose Study of SAR443820 in Healthy Adult Participants

Who this might be right for
Amyotrophic Lateral Sclerosis (Healthy Volunteers)
Sanofi 84
Not applicableStudy completedNCT01768910
What this trial is testing

Supraspinal Control of Lower Urinary Tract Function in Healthy Controls and Patients With Bladder Dysfunction

Who this might be right for
Neurogenic Lower Urinary Tract DysfunctionMultiple SclerosisOveractive Bladder+1 more
University of Zurich 91
Early research (Phase 1)Study completedNCT06064539
What this trial is testing

Study of Drug-drug Interaction of the Effects of Gemfibrozil and Rifampicin on SAR442168 in Healthy Adult Subjects

Who this might be right for
Multiple Sclerosis
Sanofi 30
Early research (Phase 1)Study completedNCT00656825
What this trial is testing

Tolerability and Bioavailability of the P144 Peptide Inhibitor of TGF-β1 After Topical Administration in Healthy Volunteers

Who this might be right for
Healthy
ISDIN 36
Early research (Phase 1)Study completedNCT06683612
What this trial is testing

PET Study of PIPE-791 in Healthy Volunteers and Volunteers With PrMS and IPF

Who this might be right for
Idiopathic Pulmonary Fibrosis (IPF)Idiopathic Pulmonary FibrosisMultiple Sclerosis+6 more
Contineum Therapeutics 16
Early research (Phase 1)Study completedNCT01802931
What this trial is testing

GSK239512 DDI Study

Who this might be right for
Multiple Sclerosis
GlaxoSmithKline 22
Post-approval studies (Phase 4)Study completedNCT01085318
What this trial is testing

Rebif Advanced Magnetic Resonance Imaging (MRI) and Immunology Pilot Trial

Who this might be right for
Multiple Sclerosis
EMD Serono 38
Early research (Phase 1)Study completedNCT02310048
What this trial is testing

Comparative Oral Bioavailability Study of MT-1303

Who this might be right for
Relapsing-remitting Multiple Sclerosis
Tanabe Pharma Corporation 34
Not applicableStudy completedNCT05654818
What this trial is testing

Peripheral Immunological Effects of High-dose Vitamin D Treatment in Healthy Subjects

Who this might be right for
Vitamin d Deficiency
Centre Hospitalier Universitaire de Nīmes 56
Not applicableStudy completedNCT00094068
What this trial is testing

The Effect of Sildenafil Citrate (Viagra® (Registered Trademark)) on Brain Blood Flow in Multiple Sclerosis Patients

Who this might be right for
Multiple Sclerosis
National Institutes of Health Clinical Center (CC) 76
Early research (Phase 1)Study completedNCT02293967
What this trial is testing

Mass Balance Study of MT-1303

Who this might be right for
Relapsing-remitting Multiple Sclerosis
Tanabe Pharma Corporation 8
Early research (Phase 1)Study completedNCT01031199
What this trial is testing

Evaluation of the Positron Emission Tomography (PET) Tracer ZK 6032924 in Patients With Multiple Sclerosis Compared to Healthy Volunteers

Who this might be right for
Positron-Emission TomographyMultiple Sclerosis
Bayer 16
Next Page